Section 32 Fund 2, LP 3
3 · Fulcrum Therapeutics, Inc. · Filed Jul 17, 2019
Insider Transaction Report
Form 3
Section 32 Fund 2, LP
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (464,285 underlying)
Footnotes (2)
- [F1]The Series B Preferred Stock is convertible into Common Stock on a seven-for-one basis into the number of shares of Common Stock as shown in Column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
- [F2]The reported securities are held of record by Section 32 Fund 2, LP ("Fund 2"). Section 32 GP 2, LLC (the "GP"), the general partner of Fund 2, and William J. Maris, the managing member of the GP, may be deemed to share voting and dispositive power over the shares held by Fund 2. Such person and entity disclaim beneficial ownership of shares held by Fund 2 except to the extent of any pecuniary interest therein.